blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1918305

EP1918305 - New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.10.2009
Database last updated on 19.10.2024
Most recent event   Tooltip30.10.2009Application deemed to be withdrawnpublished on 02.12.2009  [2009/49]
Applicant(s)For all designated states
Biogen Idec Inc.
14 Cambridge Center
Cambridge, MA 02142 / US
[N/P]
Former [2008/19]For all designated states
Biogen Idec Inc.
14 Cambridge Center
Cambridge MA 02142 / US
Inventor(s)01 / Rastetter, William
17153 El Mirador
Rancho Santa Fe, CA 92067 / US
02 / White, Christine
P.O. Box 9242
Rancho Santa Fe, CA 92067 / US
 [2008/30]
Former [2008/19]01 / Rastetter, William
16067 Puerta del Sol
Rancho Santa Fe, CA 92067 / US
02 / White, Christine
P.O. Box 9242
Rancho Santa Fe, CA 92067 / US
Representative(s)Adams, Harvey Vaughan John
Mathys & Squire LLP The Shard
32 London Bridge Street
London SE1 9SG / GB
[N/P]
Former [2008/19]Adams, Harvey Vaughan John
Mathys & Squire 120 Holborn
London EC1N 2SQ / GB
Application number, filing date08101697.431.07.2000
[2008/19]
Priority number, dateUS19990148288P11.08.1999         Original published format: US 148288 P
US2000062585626.07.2000         Original published format: US 625856
[2008/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1918305
Date:07.05.2008
Language:EN
[2008/19]
Search report(s)(Supplementary) European search report - dispatched on:EP02.04.2008
ClassificationIPC:C07K16/28, A61K39/395
[2008/19]
CPC:
C07K16/2896 (EP); A61P35/00 (EP); A61K2039/505 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2008/19]
TitleGerman:Neue klinische Parameter zur Bestimmung der hämatologischen Toxizität vor einer Strahlenimmuntherapie[2008/19]
English:New clinical parameters for determining hematologic toxicity prior to radioimmunotherapy[2008/19]
French:Nouveaux paramètres cliniques pour déterminer la toxicité hématologique avant une radioimmunothérapie[2008/19]
Examination procedure07.11.2008Examination requested  [2008/51]
04.12.2008Despatch of a communication from the examining division (Time limit: M06)
16.06.2009Application deemed to be withdrawn, date of legal effect  [2009/49]
17.07.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/49]
Parent application(s)   TooltipEP00959150.4  / EP1207904
Fees paidRenewal fee
15.02.2008Renewal fee patent year 03
15.02.2008Renewal fee patent year 04
15.02.2008Renewal fee patent year 05
15.02.2008Renewal fee patent year 06
15.02.2008Renewal fee patent year 07
15.02.2008Renewal fee patent year 08
25.07.2008Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.07.200910   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO9411026  (IDEC PHARMA CORP [US]);
by applicantUS4636380
 US4831175
 US5099069
 WO9207466
 US5124471
 US5246692
 US5286850
 US5460785
 US5843398
 US5843439
 US6399061
 US2002102208
 US6682734
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.